IMAJ | volume 27
Journal 12, December 2025
pages: 806-812
1 Pulmonary Institute, Rabin Medical Center (Beilinson Campus), Petah Tikva, Israel
2 Department of Neurology, Rabin Medical Center (Beilinson Campus), Petah Tikva, Israel
3 Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel
4 National Hemophilia Center and Thrombosis and Hemostasis Institute, Sheba Medical Center, Tel Hashomer, Israel
Summary
Cerebral arterial air embolism (CAAE) is a rare, but often fatal, complication of interventional bronchoscopy. Despite its rarity, a high index of suspicion can facilitate early diagnosis and prompt treatment. Standard of care treatment for CAAE is hyperbaric oxygen therapy, despite limited definitive data supporting its efficacy, given the conceptual potential for reversibility of neurological impairment. We describe five cases from our institution, and review the clinical presentation, pathophysiology, diagnosis, and management of suspected CAAE. Based on published case reports involving transbronchial lung biopsies (TBLB), standard of care treatment for CAAE secondary to TBLB is hyperbaric oxygen therapy, although its efficacy in this context has not been unambiguously validated in clinical practice.